Health minister

[Press Release] UNFPA scaling up emergency response to reach women and girls in Türkiye and Syria in aftermath of powerful earthquakes

Retrieved on: 
Tuesday, February 7, 2023

Both the Governments of Türkiye and Syria have declared national emergencies and called for international support.

Key Points: 
  • Both the Governments of Türkiye and Syria have declared national emergencies and called for international support.
  • At least 15 million people in Türkiye and more than 7 million across Syria have been impacted by the quakes including thousands of pregnant women who need access to maternal health services.
  • UNFPA’s immediate priority is to re-establish services that are critical to the health, well-being and protection of women and girls.
  • In Syria, blankets and warm clothes in addition to dignity kits are being provided to women and girls in need.

Simple HealthKit Raises $8M to Transform Health Diagnostics and Follow-Up Care; Expands Portfolio to Include Solutions for Sexual Health, Tripledemic

Retrieved on: 
Monday, February 6, 2023

The company also has expanded its portfolio of solutions to include diagnostics for sexual health, chronic conditions such as diabetes, and the current tripledemic (COVID-19, RSV and Flu A/B) sweeping the U.S.

Key Points: 
  • The company also has expanded its portfolio of solutions to include diagnostics for sexual health, chronic conditions such as diabetes, and the current tripledemic (COVID-19, RSV and Flu A/B) sweeping the U.S.
  • Founded by a diverse team of scientists, engineers, physicians and difference-makers, including CEO Dr. Sheena Menezes, Simple HealthKit has a mission to bring health equity to underserved markets.
  • Simple HealthKit’s test for sexual health and respiratory illness are available now at the company’s web site .
  • “Simple HealthKit builds solutions for high-need and high-impact population health challenges,” said Dr. Menezes.

VERU INC. (NASDAQ: VERU) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Veru Inc. (NASDAQ: VERU)

Retrieved on: 
Tuesday, January 31, 2023

NEW YORK, Jan. 31, 2023 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class action lawsuit that has been filed on behalf of investors who purchased or acquired the common stock of Veru Inc. (“Veru” or the “Company”) (NASDAQ: VERU) between May 11, 2022 and November 9, 2022, inclusive (the “Class Period”). The lawsuit was filed in the United States District Court for the Southern District of Florida and alleges violations of the Securities Exchange Act of 1934.

Key Points: 
  • Shareholder Class Action Lawsuit or contact Peter Allocco at (212) 951-2030 or [email protected] to discuss your rights.
  • The lawsuit was filed in the United States District Court for the Southern District of Florida and alleges violations of the Securities Exchange Act of 1934.
  • Veru is primarily an oncology-based biopharmaceutical company that develops drugs for the management of breast and prostate cancers.
  • The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414.

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Generac, Veru, Gap, and Singularity and Encourages Investors to Contact the Firm

Retrieved on: 
Monday, January 30, 2023

Generac's solar offering, called the PWRcell, is a battery-based system that stores and manages electricity generated from solar panels.

Key Points: 
  • Generac's solar offering, called the PWRcell, is a battery-based system that stores and manages electricity generated from solar panels.
  • In addition, the complaint alleges that Defendants overstated the Company's earnings throughout the Class Period.
  • Throughout the Class Period, numerous consumers filed complaints with regulators, and Generac's channel partners informed the Company of the SnapRS defect.
  • As a result of Defendants misrepresentations and omissions, Generac common stock traded at artificially inflated prices during the Class Period.

Cerē Makes Romance Less Work and More Fun this Valentine's Day

Retrieved on: 
Thursday, January 26, 2023

NEW YORK, Jan. 26, 2023 (GLOBE NEWSWIRE) -- This Valentine’s Day, get serious about personal pleasure with Cerē products founded by globally recognized OB/GYN Dr. Amir Marashi, a pioneer in the sexual medicine revolution with science-based tools and educational resources aimed at maximizing and de-stigmatizing the pleasure experience. Everyone, and every couple can make room for improvement with their partners, simply by putting intimacy first. Cerē wants to help! Now the company that engineers pleasure care tools is helping people learn and explore their erogenous zones. In addition to a collection of sleek tools engineered with anatomy and physiology in mind, the brand now introduces charts highlighting these placement zones to educate people about where to use each device.

Key Points: 
  • Everyone, and every couple can make room for improvement with their partners, simply by putting intimacy first.
  • Now the company that engineers pleasure care tools is helping people learn and explore their erogenous zones.
  • “As the first physician-founded sexual wellness company, one of our biggest missions is to normalize conversations about sexual health,” explains Dr. Marashi.
  • “We’re shifting the way people think and talk about sex altogether.”
    This Valentine’s Day couples can utilize tools from Cerē to explore new ways to please each other.

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Generac, Veru, Gap, and Singularity and Encourages Investors to Contact the Firm

Retrieved on: 
Tuesday, January 24, 2023

Generac's solar offering, called the PWRcell, is a battery-based system that stores and manages electricity generated from solar panels.

Key Points: 
  • Generac's solar offering, called the PWRcell, is a battery-based system that stores and manages electricity generated from solar panels.
  • In addition, the complaint alleges that Defendants overstated the Company's earnings throughout the Class Period.
  • Throughout the Class Period, numerous consumers filed complaints with regulators, and Generac's channel partners informed the Company of the SnapRS defect.
  • As a result of Defendants misrepresentations and omissions, Generac common stock traded at artificially inflated prices during the Class Period.

VERU INC. (NASDAQ: VERU) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Veru Inc. (NASDAQ: VERU)

Retrieved on: 
Monday, January 23, 2023

NEW YORK, Jan. 23, 2023 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class action lawsuit that has been filed on behalf of investors who purchased or acquired the common stock of Veru Inc. (“Veru” or the “Company”) (NASDAQ: VERU) between May 11, 2022 and November 9, 2022, inclusive (the “Class Period”). The lawsuit was filed in the United States District Court for the Southern District of Florida and alleges violations of the Securities Exchange Act of 1934.

Key Points: 
  • Shareholder Class Action Lawsuit or contact Peter Allocco at (212) 951-2030 or [email protected] to discuss your rights.
  • The lawsuit was filed in the United States District Court for the Southern District of Florida and alleges violations of the Securities Exchange Act of 1934.
  • Veru is primarily an oncology-based biopharmaceutical company that develops drugs for the management of breast and prostate cancers.
  • The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414.

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Generac, Veru, Gap, and Singularity and Encourages Investors to Contact the Firm

Retrieved on: 
Thursday, January 19, 2023

Generac's solar offering, called the PWRcell, is a battery-based system that stores and manages electricity generated from solar panels.

Key Points: 
  • Generac's solar offering, called the PWRcell, is a battery-based system that stores and manages electricity generated from solar panels.
  • In addition, the complaint alleges that Defendants overstated the Company's earnings throughout the Class Period.
  • Throughout the Class Period, numerous consumers filed complaints with regulators, and Generac's channel partners informed the Company of the SnapRS defect.
  • As a result of Defendants misrepresentations and omissions, Generac common stock traded at artificially inflated prices during the Class Period.

VERU INC. (NASDAQ: VERU) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Veru Inc. (NASDAQ: VERU)

Retrieved on: 
Tuesday, January 17, 2023

NEW YORK, Jan. 17, 2023 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class action lawsuit that has been filed on behalf of investors who purchased or acquired the common stock of Veru Inc. (“Veru” or the “Company”) (NASDAQ: VERU) between May 11, 2022 and November 9, 2022, inclusive (the “Class Period”). The lawsuit was filed in the United States District Court for the Southern District of Florida and alleges violations of the Securities Exchange Act of 1934.

Key Points: 
  • Shareholder Class Action Lawsuit or contact Peter Allocco at (212) 951-2030 or [email protected] to discuss your rights.
  • The lawsuit was filed in the United States District Court for the Southern District of Florida and alleges violations of the Securities Exchange Act of 1934.
  • Veru is primarily an oncology-based biopharmaceutical company that develops drugs for the management of breast and prostate cancers.
  • The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414.